Mayne Pharma

Mayne Pharma Group Limited (Mayne Pharma) is a specialty pharmaceutical company listed on the Australian Securities Exchange (ASX), dedicated to commercializing branded and generic drugs by leveraging its drug delivery expertise to provide patients with better and more accessible medications. Mayne Pharma also offers contract development and manufacturing services to over 100 customers worldwide.The roots of Mayne Pharma can be traced back to FH Faulding and Co, one of the largest and most prominent publicly listed companies headquartered in South Australia for many years. Mayne Pharma is a technology-driven company with a significant portfolio and pipeline, supported by distribution partners across Australia, North America, Europe, and Asia. It operates two product development and manufacturing facilities in Salisbury, Australia, and Greenville, North Carolina, USA. Mayne Pharma specializes in complex oral and topical dosage forms, including highly potent compounds, modified-release products, and poorly soluble compounds. The company employs more than 900 people globally, including over 200 scientists.